Douglas Krulik, CAO and Interim CFO of PetMed Express Inc., filed a Form 4 on November 6, 2026, reporting four share-surrender transactions between September 27, 2025, and October 30, 2026, related to the vesting of restricted stock units and restricted stock awards.
William David Wood III, Chief Financial Officer of Agilysys, Inc., filed a Form 4 on November 6, 2026, disclosing the acquisition of 5,143 restricted stock units on November 4, 2026, under the company's 2024 Equity Incentive Plan.
Agilysys Inc. Chief Commercial Officer Joe Ahmed Youssef filed a Form 4 on November 6, 2026, disclosing the acquisition of 2,789 restricted stock units on November 4, 2026, under the company's 2024 Equity Incentive Plan.
Agilysys, Inc. SVP, General Counsel and Secretary Kyle C. Badger filed a Form 4 on November 6, 2026, disclosing the acquisition of 3,099 restricted stock units on November 4, 2026, under the company's 2024 Equity Incentive Plan.
Agilysys Inc. Chief Technology Officer Shivashankar Sethuram filed a Form 4 on November 6, 2026, disclosing the acquisition of 4,848 restricted stock units on November 4, 2026, under the company's 2024 Equity Incentive Plan.
Jason Gowans, EVP and Chief Digital and Technology Officer of Levi Strauss & Co., filed a Form 4 on November 6, 2026, disclosing the sale of 3,494 shares of Class A Common Stock on November 4, 2026.
Director Joshua E. Prime of Levi Strauss & Co. filed a Form 4 on November 6, 2026, disclosing the acquisition of 111 shares of Class A Common Stock via dividend equivalent rights on November 4, 2026.
Noor Shain, Chief Technology Officer of Silvia, Inc. (NASDAQ:SVIA), filed an amended statement of changes in beneficial ownership on November 6, 2026, correcting a July 8, 2026 original filing related to a tax-withholding transaction dated July 6, 2026.
Director Patrick Artemis filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 72 dividend equivalent rights in Levi Strauss & Co. (NASDAQ:LEVI) on November 4, 2026.
Director Jenny J. Ming filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of dividend equivalent rights tied to Levi Strauss & Co. Class A and Class B Common Stock, with transactions dated November 4, 2026.